Status:

NOT_YET_RECRUITING

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

Lead Sponsor:

University of Maryland, Baltimore

Collaborating Sponsors:

Medtronic

Conditions:

Diabetes Mellitus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SI...

Detailed Description

Diabetes is affecting millions of Americans. High glucose levels lead to complications such as heart attacks, stroke or blindness. Reducing high glucose levels may unfortunately lead to very low gluco...

Eligibility Criteria

Inclusion

  • ≥18 years of age
  • MDI insulin treated (receiving MDI for at least 3 months prior to the study)

Exclusion

  • DM patients not treated with MDI for at least 3 months (i.e diet only, any combination of non-insulin antidiabetic drugs only, basal insulin only or bolus/short acting insulin only)
  • Patients with DM at the time of screening on insulin pumps
  • Pregnant patients
  • Patients with extensive skin disease or allergies that preclude wearing the CGM sensor
  • Patients who have end-stage renal disease requiring dialysis
  • Patients with significant psychiatric illness or any other condition rendering the subject incapable of understanding the objectives and potential consequences of the study
  • Patients who receive hydroxyurea or who are on long (chronic) treatment with acetaminophen
  • Patients who were started on non-insulin DM medications or had a dose change within 60 days or less prior to study participation
  • Patient does not have or not able to gain access to a smartphone which is compatible with the necessary applications for DAT

Key Trial Info

Start Date :

November 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 30 2028

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06918977

Start Date

November 15 2025

End Date

May 30 2028

Last Update

November 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VAMHCS, Diabetes Outpatient Clinic

Baltimore, Maryland, United States, 21201